Recommended Neuroanatomical Sampling Practices for Comprehensive Brain Evaluation in Nonclinical Safety Studies

Toxicologic Pathology

Volumn 39, Issue 1, 2011, Pages 73-84

  Switzer, Robert C ^a   Lowry Franssen, Catherine ^a,b   Benkovic, Stanley A ^a  

^a NeuroScience Associates   (United States)

^b RANDOLPH MACON COLLEGE   (United States)

Author keywords

brain sampling; enhanced histopathology; neurohistology; neuropathology; neurotoxicity

Indexed keywords

ANIMAL; ANIMAL MODEL; BRAIN; CELL DEATH; CHEMICALLY INDUCED DISORDER; EVALUATION; HISTOLOGY; HUMAN; METHODOLOGY; NEUROANATOMY; NEUROLOGIC DISEASE; PATHOLOGY; PHYSIOLOGY; REVIEW; TOXICITY AND INTOXICATION;

ANIMALS; BRAIN; CELL DEATH; EVALUATION STUDIES AS TOPIC; HISTOLOGICAL TECHNIQUES; HUMANS; MODELS, ANIMAL; NERVOUS SYSTEM DISEASES; NEUROANATOMY; NEUROTOXICITY SYNDROMES; RESEARCH DESIGN;

EID: 79959509649     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623310397557     Document Type: Article

References (52)

1. Belcher A. M. O’Dell S. J. Marshall J. F. (2005). Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity. Neuropsychopharmacol 30, 2026–34.
2. Benkovic S. A. O’Callaghan J. P. Miller D. B. (2004). Sensitive indicators of injury reveal hippocampal damage in C57BL/6J mice treated with kainic acid in the absence of tonic-clonic seizures. Brain Res 1024, 59–76.
3. Benkovic S. A. O’Callaghan J. P. Miller D. B. (2006). Regional neuropathology following kainic acid intoxication in adult and aged C57BL/6J mice. Brain Res 1070, 215–31.
4. Bolon B. Bradley A. Butt M. Jensen K. Krinke G. Mellon R. D. (2010 Nov 30). Compilation of international regulatory guidance documents for neuropathology assessment during nonclinical toxicity studies. Toxicol Pathol [Epub ahead of print].
5. Bowyer J. F. (2000). Neuronal degeneration in the limbic system of weanling rats exposed to saline, hyperthermia or d-amphetamine. Brain Res 885, 166–71.
6. Bowyer J. F. Delongchamp R. R. Jakab R. L. (2004). Glutamate N-methyl-D-aspartate and dopamine receptors have contrasting effects on the limbic versus the somatosensory cortex with respect to amphetamine-induced neurodegeneration. Brain Res 1030, 234–46.
7. Bowyer J. F. Peterson S. L. Rountree R. L. Tor-Agbidye J. Wang G. J. (1998). Neuronal degeneration in rat forebrain resulting from amphetamine-induced convulsions is dependent on seizure severity and age. Brain Res 809, 77–90.
8. Carlson J. Armstrong B. Switzer R. C. 3rd Ellison G. (2000). Selective neurotoxic effects of nicotine on axons in fasciculus retroflexus further support evidence that this is a weak link in brain across multiple drugs of abuse. Neuropharmacology 39, 2792–98.
9. Colman J. R. Nowocin K. J. Switzer R. C. Trusk T. C. Ramsdell J. S. (2005). Mapping and reconstruction of domoic acid-induced neurodegeneration in the mouse brain. Neurotoxicol Teratol 27, 753–67.
10. Creeley C. Wozniak D. F. Labruyere J. Taylor G. T. Olney J. W. (2006). Low doses of memantine disrupt memory in adult rats. J Neurosci 26, 3923–32.
11. Creeley C. E. Wozniak D. F. Nardi A. Farber N. B. Olney J. W. (2006). Donezepil markedly potentiates memantine neurotoxicity in the adult rat brain. Neurobiol Aging 29, 153–67.
12. Crews F. T. Braun C. J. Hoplight B. Switzer R. C. 3rd Knapp D. J. (2000). Binge ethanol consumption causes differential brain damage in young adolescent rats compared with adult rats. Alcohol Clin Exp Res 24, 1712–23.
13. Desclin J. Escubi J. (1974). Effects of 3-acetylpyridine on the central nervous system of the rat, as demonstrated by silver methods. Brain Res 77, 349–64.
14. Ellison G. (1995). The N-methyl--aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Rev 20, 250–67.
15. Ellison G. (2002). Neural degeneration following chronic stimulant abuse reveals a weak link in brain, fasciculus retroflexus, implying the loss of forebrain control circuitry. Eur Pharmacol 12, 287–97.
16. Fix A. S. Long G. G. Wozniak D. F. Olney J. W. (1994). Pathomorphologic effects of N-methyl-D-aspartate antagonists in the rat posterior ingulate/retrosplenial cerebral cortex: A review. Drug Development Research, 32(3): p. 147–52.
17. Fix A. S. Horn J. W. Wightman K. A. Johnson C. A. Long G. G. Storts R. W. Farber N. Wozniak D. F. Olney J. W. (1993). Neuronal vacuolization and necrosis induced by the noncompetitve N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizolcilpine maleate): a light and electron microscope evaluation of the rat retrosplenial cortex. Exp Neurol 123, 204–15.
18. Fix A. S. Ross J. F. Stitzel S. R. Switzer R. C. (1996). Integrated evaluation of central nervous system lesions: stains for neurons, astrocytes, and microglia reveal the spatial and temporal features of MK-801-induced neuronal necrosis in the rat cerebral cortex. Toxicol Pathol 24, 291–304.
19. Fix A. S. Wozniak D. F. Truex L. L. McEwen M. Miller J. P. Olney J. W. (1995). Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex. Brain Res 696, 194–204.
20. Han J. Y. Joo Y. Kim Y. S. Lee Y. K. Kim H. J. Cho G. J. Choi W. S. Kang S. S. (2005). Ethanol induces cell death by activating caspase-3 in the rat cerebral cortex. Mol Cells 20, 189–95.
21. Harry J. (2001). Neurotoxic Risk Assessement for Human Health: Principles and Approaches. Geneva: World Health Organization.
22. Harvey J. A. McMaster S. E. Yunger L. (1975). p-Chloroamphetamine: selective neurotoxic action in brain. Science 187, 841–43.
23. Horvath Z. C. Czopf J. Buzsaki G. (1997). MK-801-induced neuronal damage in rats. Brain Res 753, 181–95.
24. Ikegami Y. Goodenough S. Inoue Y. Dodd P. R. Wilce P. A. Matsumoto I. (2003). Increased TUNEL positive cells in human alcoholic brains. Neurosci Lett 349, 201–5.
25. Jakab R. L. Bowyer J. F. (2002). Parvalbumin neuron circuits and microglia in three dopamine-poor cortical regions remain sensitive to amphetamine exposure in the absence of hyperthermia, seizure and stroke. Brain Res 958, 52–69.
26. Jakab R. L. Bowyer J. F. (2004). The injured neuron/phagocytic microglia ration “R” reveals the progression and sequence of neurodegeneration. Toxicological Sciences. Abstract #309, The Toxicologist CD - An official Journal of the Society of Toxicology, Volume 78, Number S-1, March 2004.
27. Jensen K. F. Olin J. Haykal-Coates N. O'Callaghan J. P. Miller D. B. de Olmos J. S. (1993) Mapping toxicant-induced nervous system damage with a cupric silver stain: a quantitative analysis of neural degeneration induced by 3,4-methylenedioxymethamphetamine. NIDA Res Monogr. 136: 133–149.
28. Jevtovic-Todorovic V. Beals J. Benshoff N. Olney J. W. (2003). Prolonged exposure to inhalational anesthetic nitrous oxide kills neurons in adult rat brain. Neuroscience 122, 609–16.
29. Jevtovic-Todorovic V. Benshoff N. Olney J. W. (2000). Ketamine potentiates cerebrocortical damage induced by the common anaesthetic agent nitrous oxide in adult rats. Br J Pharmacol 130, 1692–698.
30. Jevtovic-Todorovic V. Hartman R. E. Izumi Y. Benshoff N. D. Dikranian K. Zorumski C. F. Olney J. W. Wozniak D. F. (2003). Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 23, 876–82.
31. Johnson E. A. O’Callaghan J. P. Miller D. B. (2002). Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse. Brain Res 933, 130–38.
32. Johnson E. A. Shvedova A. A. Kisin E. O’Callaghan J. P. Kommineni C. Miller D. B. (2002). d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity. Brain Res 933, 150–63.
33. Luellen B. A. Miller D. B. Chisnell A. C. Murphy D. L. O’Callaghan J. P. Andrews A. M. (2003). Neuronal and Astroglial Responses to the Serotonin and Norepinephrine Neurotoxin: 1-Methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine. J Pharmacol Exp Ther 307, 923–31.
34. Maas J. W. Indacochea R. A. Muglia L. M. Tran T. T. Vogt S. K. West T. Benz A. Shute A. A. Holtzman D. M. Mennerick S. Olney J. W. Muglia L. J. (2005). Calcium-stimulated adenylyl cyclases modulate ethanol-induced neurodegeneration in the neonatal brain. J Neurosci 25, 2376–85.
35. Miller P. J. Zaborsky L. (1997). 3-Nitropropionic acid neurotoxicity: Visualization by silver staining and implications for use as an animal model of Huntington’s Disease. Exp Neurol 1146, 212–29
36. Morrison J. Ton T. Collins J. Switzer R. Little P. Morgan D. Sills R. C. (2009). Gene expression studies reveal that DNA damage, vascular perturbation, and inflammation contribute to the pathogenesis of carbonyl sulfide neurotoxicity. Toxicol Pathol 37, 502–11.
37. Olney J. W. (2003). Excitotoxicity, apoptosis and neuropsychiatric disorders. Curr Opin Pharmacol 3, 101–9.
38. Olney J. W. Farber N. B. Wozniak D. F. Jevtovic-Todorovic V. Ikonomidou C. (2000). Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain. Environ Health Perspect 108(Suppl 3), 383–88.
39. Olney J. W. Ikonomidou C. Mosinger J. L. Frierdich G. (1989). MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J Neurosci 9, 1701–4.
40. Olney J. W. Labruyere J. Price M. T. (1989). Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244, 1360–362.
41. Olney J. W. Price M. Salles K. S. Labruyere J. Frierdich G. (1987). MK-801 powerfully protects against N-methyl aspartate neurotoxicity. Eur J Pharmacol 141, 357–61.
42. Olney J. W. Young C. Wozniak D. F. Jevtovic-Todorovic V. Ikonomidou C. (2004). Do pediatric drugs cause developing neurons to commit suicide? Trends Pharmacol Sci 25, 135–39.
43. O’Shea E. Granados R. Esteban B. Colado M. I. Green A. R. (1998). The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (“ecstasy”). Neuropharmacology 37, 919–26.
44. Paxinos G. Watson C. (1982). The Rat Brain in Stereotaxic Coordinates, 1st ed. Academic Press, Sydney, Australia.
45. Paxinos G. Watson C. (2007). The Rat Brain in Stereotaxic Coordinates, 6th ed. Elsevier, Sydney, Australia.
46. Schmued L. C. Bowyer J. F. (1997). Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants. Brain Res 759, 135–40.
47. Schmued L. C. Hopkins K. J. (2000). Fluoro-Jade B: A high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874, 123–30.
48. Switzer R. C. (2000). Application of silver degeneration stains for neurotoxicity testing. Toxicol Pathol 28, 70–83.
49. United States Food Drug Administration (2000, July 7). Redbook 2000: Toxicological Principles for the Safety Assessment of Food Ingredients. IV.C.10 Neurotoxicity Studies. Washington, D. C.: Department of Health and Human Services.
50. Wilson M. A. Molliver M. E. (1994). Microglial response to degeneration of serotonergic axon terminals. Glia 11, 18–34.
51. Wong E. Kemp J. Priestley T. Knight A. Woodruff G. Iversen L. (1986). The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A 83, 7104–8.
52. Wozniak D. F. Dikranian K. Ishimaru M. J. Nardi A. Corso T. D. Tenkova T. Olney J. W. Fix A. S. (1998). Disseminated corticolimbic neuronal degeneration induced in rat brain by MK-801. Neurobiol Dis 5, 305–22.